Skip to content

XOMA Corporation XOMA Accounts payable and other current liabilities

Accounts payable and other current liabilities at other companies

Zymeworks logo
ZymeworksZYME
-$7.75M+63.5%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$9.41M-176%

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's accounts payable and other current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's accounts payable and other current liabilities?
XOMA Corporation (XOMA) reported accounts payable and other current liabilities of -$2.63M in Q1 2026.
How has XOMA Corporation's accounts payable and other current liabilities changed year-over-year?
XOMA Corporation's accounts payable and other current liabilities increased by 19.5% year-over-year, from -$3.27M to -$2.63M.